Innovation Recognition Cionic is positioned as a globally innovative player, evidenced by being named to Fast Company's World’s Most Innovative Companies of 2026 and TIME Best Inventions for Neural Sleeve 2. This enhances credibility when engaging with hospitals, clinics, and research partners seeking cutting-edge mobility solutions.

FDA Cleared Core With the Neural Sleeve 2 FDA-cleared and designed to choreograph muscle activation and relaxation, target opportunities exist in neuromuscular rehabilitation, MS care, and mobility impairment clinics seeking compliant wearable neurotechnology integration.

Collaborations & Outreach Strategic partnerships, including the National MS Society, indicate a channel for co-development, patient support programs, and expanded adoption within patient networks, suggesting sales routes through non-profit and advocacy groups.

Product Expansion Launch of the MultiStim system and ongoing software updates signal an opportunity to upsell to current Neural Sleeve users and to enterprise customers seeking integrated, multi-pulse stimulation workflows in rehab centers and research institutions.

Growth & Finance Mid-sized revenue range and $35M in funding, alongside rapid product iteration and a focused team, point to scalable deployments with hospitals and clinics, especially those investing in digital therapeutics and connected care for mobility.